Cargando…

Development and application of a novel model to predict the risk of non-alcoholic fatty liver disease among lean pre-diabetics with normal blood lipid levels

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has been associated with type 2 diabetes, but its relationship with pre-diabetes is still unknown. This study aims to determine whether pre-diabetes is associated with NAFLD, followed by establishing a NAFLD predictive nomogram for lean Chinese p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Wentao, Shi, Pei, Fu, Jiwei, Liang, An, Zheng, Ting, Wu, Xiaoping, Yuan, Songsong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804963/ https://www.ncbi.nlm.nih.gov/pubmed/36585668 http://dx.doi.org/10.1186/s12944-022-01752-5

Ejemplares similares

Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels
por: Zhu, Wentao, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease in lean individuals
por: Albhaisi, Somaya, et al.
Publicado: (2019)

Avicularin alleviates acute liver failure by regulation of the TLR4/MyD88/NF‐κB and Nrf2/HO‐1/GPX4 pathways to reduce inflammation and ferroptosis
por: Shi, Pei, et al.
Publicado: (2023)

The combination of serum oligosaccharide chain (G-test), alpha-fetoprotein, and aspartate aminotransferase to alanine aminotransferase ratio provides the optimal diagnostic value for early detection of hepatocellular carcinoma
por: Zhu, Wentao, et al.
Publicado: (2022)

Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications
por: Kumar, Ramesh, et al.
Publicado: (2017)

Lean non-alcoholic fatty liver disease: do not forget diabetes
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2019)

Lean non-alcoholic fatty liver disease (Lean-NAFLD) and the development of metabolic syndrome: a retrospective study
por: Wang, Wenting, et al.
Publicado: (2022)

Predictivity of fatty liver index for non-alcoholic fatty liver disease in lean females with polycystic ovary syndrome
por: Arıkan, Didem, et al.
Publicado: (2022)

Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population
por: Li, Min-ran, et al.
Publicado: (2023)

Clinical Differences and Non-Alcoholic Fatty Liver Disease-Related Factors of Lean and Non-Lean Patients with Metabolic Syndrome
por: Boonchai, Punyisa, et al.
Publicado: (2022)

Comparison of Machine Learning Models and the Fatty Liver Index in Predicting Lean Fatty Liver
por: Su, Pei-Yuan, et al.
Publicado: (2023)

Genetic variants in HFE are associated with non-alcoholic fatty liver disease in lean individuals
por: Sun, Zewen, et al.
Publicado: (2023)

Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals
por: Aneni, Ehimen C., et al.
Publicado: (2022)

Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
por: Han, Eugene, et al.
Publicado: (2023)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2021)

The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study
por: Aneni, Ehimen C., et al.
Publicado: (2020)

Association of Low Skeletal Muscle Mass with the Phenotype of Lean Non-Alcoholic Fatty Liver Disease
por: Byeon, Jun-Hyeon, et al.
Publicado: (2022)

Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
por: Chao, Hsu-Wen, et al.
Publicado: (2019)

Shifting perspectives – interplay between non-alcoholic fatty liver disease and insulin resistance in lean individuals
por: Bilic-Curcic, Ines, et al.
Publicado: (2021)

Fatty liver in lean patients: is it a different disease?
por: Verdelho Machado, Mariana, et al.
Publicado: (2012)

Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2023)

Lipid droplet dynamics in alcoholic fatty liver disease
por: Schulze, Ryan J., et al.
Publicado: (2019)

Fasting glucose mediates the influence of genetic variants of SOD2 gene on lean non-alcoholic fatty liver disease
por: Wu, Na, et al.
Publicado: (2022)

Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease
por: Li, Ting, et al.
Publicado: (2019)

Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
por: Patoulias, Dimitrios, et al.
Publicado: (2020)

Pemafibrate therapy for non-alcoholic fatty liver disease is more effective in lean patients than obese patients
por: Shinozaki, Satoshi, et al.
Publicado: (2022)

Adiponectin–leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance
por: Lu, Chia-Wen, et al.
Publicado: (2023)

Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities
por: Wijarnpreecha, Karn, et al.
Publicado: (2023)

HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels
por: Chen, Changxi, et al.
Publicado: (2020)

Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case – control study
por: Feng, Rennan, et al.
Publicado: (2017)

Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects
por: Yun, Yeojun, et al.
Publicado: (2019)

Lean Patients with Non-Alcoholic Fatty Liver Disease Have a Severe Histological Phenotype Similar to Obese Patients
por: Denkmayr, Lukas, et al.
Publicado: (2018)

Lean non‐alcoholic fatty liver disease and associated metabolic disturbance: A Saudi Arabian cross‐sectional study
por: Khayyat, Yasir Mohammed
Publicado: (2021)

Long working hours and increased risks of lean non-alcoholic fatty liver disease among Korean men and women
por: Lim, Ga-Young, et al.
Publicado: (2023)

Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease
por: Liao, Chia-Jung, et al.
Publicado: (2022)

Predictive Risk Factors of Nonalcoholic Fatty Liver Disease in a Lean Chinese Population
por: Liu, Lu, et al.
Publicado: (2022)

Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism
por: Wang, Songsong, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
por: Chrysavgis, Lampros, et al.
Publicado: (2020)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9agufi1h0a43mr1r7sqtv0jois